AnAPN1 targeting malaria vaccine (CellFree/University of Florida)

N/A

Report date: 2025/03/14 16:44:02

Base Information

Drug NameAnAPN1 targeting malaria vaccine (CellFree/University of Florida)
Drug Alias Nameanopheline mosquito midgut-specific alanyl aminopeptidase N targeting malaria vaccine (CellFree/University of Florida)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria, VivaxMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAfricaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellfree Sciences Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMalaria, VivaxMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A